Delivery Order SPE2DB24D2010-SPE2DB25FABDX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units, with a ceiling value of $6,023.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Citalopram HBR 40 mg tablets (500-count units) with a ceiling value of $12,406.14. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $2,247.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (100 count) on September 9, 2025, with completion scheduled for September 10, 2025. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was made without set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Citalopram HBr 20 mg tablets (500 count) valued at $1,582.47. This firm fixed-price delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a $16,451.57 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 500 tablets of Citalopram HBR 40 mg, with completion expected by September 5, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,355.52 firm fixed-price delivery order contract is for the supply of 4,566,197,995 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 500 tablets of Citalopram HBR 40 mg. The $8,615.28 contract has a completion date of January 5, 2024. AmerisourceBergen Drug Corp, as a prime contractor, has previously supplied pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order is not associated with a...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABDXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,210.57 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical distribution relationship with the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a broad range of medications and medical commodities to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The firm fixed pricing structure and consistent delivery order awards demonstrate the contractor's established capability to fulfill federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 9/11/25 |